Dr. Noah Bindman, PhDScientific Director of ADC Engineering at PfizerSpeaker
Profile
Dr. Noah Bindman, PhD, is currently Scientific Director of ADC Engineering at Pfizer. Noah joined the Oncology Research Unit of Pfizer in 2024 as part of the acquisition of Seagen. Noah previously spent 8 years at Seagen, focused on the development of next-generation MMAE ADCs.
Agenda Sessions
Insights from Two Decades of Clinical and Preclinical Experience with MMAE ADCs
, 11:00View Session
